Securities code: 000950 securities abbreviation: C.Q.Pharmaceutical Holding Co.Ltd(000950) Announcement No.: 2022 – 002 C.Q.Pharmaceutical Holding Co.Ltd(000950)
Approval for registration of ultra short term financing bonds of holding subsidiaries and
Announcement on the issuance results of the first phase of ultra short term financing bonds in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
The 40th meeting of the seventh board of directors and the second extraordinary general meeting in 2021 of C.Q.Pharmaceutical Holding Co.Ltd(000950) (hereinafter referred to as “the company”) deliberated and approved the proposal on the proposed issuance of debt financing products by the holding subsidiary heavy Pharmaceutical Co., Ltd., and agreed to newly register and issue debt financing products by Chongqing pharmaceutical (Group) Co., Ltd. (hereinafter referred to as “heavy Pharmaceutical Co., Ltd”) in 2021, The categories of financing products include but are not limited to ultra short-term financing bonds and medium-term notes. Among them, the proposed new registered issuance scale of ultra short-term financing bonds shall not exceed RMB 5 billion (inclusive), and the issuance period shall not exceed 270 days (inclusive). For details, please refer to the announcement on the resolution of the 40th meeting of the 7th board of directors (Announcement No.: 2021-025) disclosed on cninfo.com on April 14, 2021 and the announcement on the resolution of the second extraordinary general meeting of shareholders in 2021 (Announcement No.: 2021-051) disclosed on April 30, 2021.
Recently, Chongqing pharmaceutical Co., Ltd. has received the notice of acceptance of registration (zsxzz [2021] scp533) (hereinafter referred to as “this registration notice”) issued by Bank Of China Limited(601988) market dealers association (hereinafter referred to as “Dealers Association”) and agreed to accept the registration of ultra short-term financing bonds of Chongqing Pharmaceutical Co., Ltd. the main contents are as follows:
1、 The registered amount of super short-term financing bonds of heavy Pharmaceutical Co., Ltd. is RMB 4 billion, and the registered amount is valid within 2 years from the date of signing this registration notice, which is jointly underwritten by China Everbright Bank Company Limited Co.Ltd(601818) and Ping An Bank Co.Ltd(000001) .
2、 Heavy pharmaceutical shares can issue ultra short-term financing bonds by stages within the registration validity period. After the issuance is completed, the issuance results shall be disclosed through the channels approved by the Dealer Association.
Chongqing pharmaceutical Co., Ltd. will perform the obligation of information disclosure in strict accordance with the rules for the registration and issuance of debt financing instruments of non-financial enterprises, the working procedures for the public issuance and registration of debt financing instruments of non-financial enterprises, the rules for the information disclosure of debt financing instruments of non-financial enterprises and the guidelines of relevant rules.
The first phase of ultra short term financing bonds (Rural Revitalization) of Chongqing pharmaceutical (Group) Co., Ltd. in 2022 was issued on January 12, 2022, and the raised funds were received on January 13, 2022. The issuance results are hereby announced as follows:
Chongqing pharmaceutical (Group) Co., Ltd. 22 Chongqing pharmaceutical scp001 (township name) phase I ultra short term financing bonds in 2022 (Village revitalization for short)
Revitalization)
Code 012280193 period 180 days
Value date January 13, 2022 payment date July 12, 2022
The planned issuance is 200 million yuan, and the actual total issuance is 200 million yuan
total
The issuing interest rate is 3.75%, and the issuing price is 100 yuan / 100 yuan face value
Lead underwriter China Everbright Bank Company Limited Co.Ltd(601818)
The documents related to the issuance of ultra short-term financing bonds are available on www.chinamoney.com.cn And Shanghai clearing house (www.shclearing. Com.) Make an announcement on the Internet.
Heavy Pharmaceutical Co., Ltd. is not the subject of dishonesty responsibility.
Up to now, under this registration notice, heavy Pharmaceutical Co., Ltd. has issued one phase of ultra short-term financing bonds, with a cumulative issuance amount of RMB 200 million. After the issuance of this period, the balance of ultra short-term financing bonds of Chongqing pharmaceutical Co., Ltd. is RMB 1.2 billion (including RMB 1 billion of ultra short-term financing bonds existing under the notice of acceptance of registration [2019] scp387), and the remaining amount is RMB 3.8 billion.
It is hereby announced
C.Q.Pharmaceutical Holding Co.Ltd(000950) board of directors January 14, 2022
